Betaine can also inhibit high-mobility group box protein 1/TLR4 signal transduction, which may be one of the mechanisms of betaine in the treatment of liver injury in rats with non-alcoholic fatty liver disease [25]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.